The U.S. Supreme Court is refusing to hear an appeal seeking to reinstate an Oklahoma law that would effectively ban abortion-inducing drugs. In Texas, opponents of an abortion law are appealing to the Supreme Court to reinstate their injunction against the law that requires those performing the procedure have admitting privileges at nearby hospitals.
Los Angeles Times: High Court's Refusal To Hear Oklahoma Appeal Is Blow to Abortion Forces
The legal push in some Republican-controlled states to restrict abortion rights suffered a setback Monday when the U.S. Supreme Court declined to hear Oklahoma's appeal seeking to reinstate a law that effectively banned the use of abortion-inducing drugs. The court's decision delivered a surprise victory for abortion rights groups and was seen as a sign that while conservative justices may be open to giving states new powers to restrict abortion, they are not ready to impose sweeping new limits that would significantly interfere with women's constitutionally protected rights (Savage and Hennessy-Fiske, 11/4).
Los Angeles Times: Opponents Of New Texas Abortion Law Appeal To Supreme Court
Planned Parenthood and others opponents of new Texas abortion restrictions have appealed to the U.S. Supreme Court to reinstate an injunction blocking portions of the law concerning doctors' admitting privileges. The appeal was filed with U.S. Supreme Court Justice Antonin Scalia, who gave state officials until next Tuesday to file a response before he rules. Scalia could rule on the injunction himself or refer the issue to the full court (Hennessy-Fiske, 11/4).
The Texas Tribune: Abortion Providers Ask SCOTUS To Reinstate Injunction
Abortion providers on Monday asked the U.S. Supreme Court to reinstate a lower federal court's injunction that blocked Texas from implementing strict new abortion rules…The 5th Circuit Court of Appeals on Thursday lifted a lower court’s injunction, allowing the state to implement two provisions in House Bill 2 that require abortion providers to obtain hospital admitting privileges nearby the facility and follow federal guidelines, rather than a common, evidence-based protocol, when administering drug-induced abortions (Aaronson, 11/4).